DNAJC5 and hepatocellular carcinoma: In the present study, we show that antibodies against target antigens different from CSP are able to prevent sporozoite infection of a human hepatoma cell line in vitro and are able to reduce liver burden in humanized FRG-huHep mice in vivo.